DAVID GRANOVSKY

StemCells Inc’s (NASD: STEM) Advancement

In BUSINESS OF STEM CELLS on September 3, 2009 at 12:48 pm

stemcellslogoStemCells Inc’s (NASD: STEM) announced a significant advance in its stem cell therapeutic program.  Positive results from a study of the company’s HuCNS-SC cells (purified human neural stem cells) were published as the cover story in the latest issue of Cell Stem Cell, a leading scientific journal focused in the area of stem cells.

The findings of this study represent a key advance in the evaluation of stem cells as potential therapies for human diseases as it demonstrates for the first time that StemCells’ HuCNS-SC cells are able to delay the loss of motor function in a mouse model of NCL.  The company has already demonstrated that HuCNS-CS has a favorable safety profile in human patients with NCL (Phase 1 study results announced in June 2009).  These latest study results suggest that HuCNS-SC cells may ultimately represent a breakthrough treatment for neurodegenerative diseases such as NCL for which there are currently no cures.

via http://www.stemcellsinc.com/news/090903a.html

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: